Last reviewed · How we verify

NCT05457764

Erotica by Virtual Reality on Sperm Donors

Completed NA Last updated 14 July 2022
What this trial tests

NA trial testing Virtual reality headset in Virtual Reality in 63 participants. Completed in 25 November 2021.

Timeline
1 August 2021
Primary endpoint
25 November 2021
25 November 2021

Quick facts

Lead sponsorCryos International
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposebasic science
Enrollment63
Start date1 August 2021
Primary completion25 November 2021
Estimated completion25 November 2021
Sites4 locations across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Cryos International

Who can join

Adults 19 to 44, male only, with Virtual Reality. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective To study whether erotica by virtual reality (VR) during masturbation influences the quality of sperm donor ejaculates. Hypothesis Erotica by virtual reality improves ejaculate quality.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of virtual reality erotica on ejaculate quality of sperm donors: a balanced and randomized controlled cross-over within-subjects trial.
    Rosenkjær D, Pacey A, Montgomerie R, Skytte AB. · · 2022 · cited 1× · PMID 36221120 · DOI 10.1186/s12958-022-01021-1

Verify or expand the search:

Other trials of Virtual reality headset

Trials testing the same drug.

Other recruiting trials for Virtual Reality

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05457764.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing